Industry Spotlight

Biotron says new study backs BIT225 development

2 May 2017 via Biotech Dispatch: Biotron (ASX:BIT) says a recently published scientific paper validates it approach of using its lead clinical compound, BIT225, to target the elimination of HIV-1 in macrophages. The study, published in the Nature Medicine, reported ... | READ MORE

Opthea completes $45m capital raise

2 May 2017 via Biotech Dispatch: Opthea (ASX:OPT), a developer of novel biologic therapies for the treatment of eye diseases, has completed a $45 million capital raise. The company said the proceeds will support acceleration and diversification of the its clinical d... | READ MORE

Budget key for MRFF

27 April 2017 via Biotech Dispatch: One of many questions to be answered in the upcoming Budget could be the future direction of the Medical Research Future Fund. The Fund, announced in the 2014-15 Budget as a $20 billion endowment to support Australian medical rese... | READ MORE

Starpharma triggers milestone payment from AZ

27 April 2017 via Biotech Dispatch: Australian company Starpharma has reached another milestone in its partnership with AstraZeneca covering development of its DEP drug delivery technology. The milestone has triggered a US$2 million milestone payment under Starpharm... | READ MORE

Sector concern over scrapping of 457 visas

20 April 2017 via Biotech Dispatch: Questions across the life sciences sector after the Turnbull government announced major changes to section 457 visas for temporary skilled migrants. In immediate changes, a number of occupations important to the life sciences sect... | READ MORE

IP Australia delays legislation

20 April 2017 via Biotech Dispatch: Government will not proceed with legislation designed to align and streamline the processes for obtaining, maintaining and challenging intellectual property rights, pending its response to last years Productivity Commission report ... | READ MORE

Extended deployment for Alcidion’s Patient Flow Solution

18 April 2017 via Biotech Dispatch: The Northern Territory Department of Health has extended their relationship with Alcidion (ASX:ALC) with deployment of the companys Patient Flow Solution throughout Katherine Hospital. According to the company, its Miya platform p... | READ MORE

Immuron announces positive results of IMM-124E in acute colitis

18 April 2017 via Biotech Dispatch: Immuron (ASX:IMC) has announced it has successfully completed the first stage of its colitis preclinical program at the University of Zurich in Switzerland. The company said it is preparing to move forward to the next development ... | READ MORE

IDT reports better than expected sales result

13 April 2017 via Biotech Dispatch: IDT Australia has reported better than expected sales following the recent US launch of its generic temozolomide. The company received FDA approval for its internally developed temozolomide brand in April 2016. Read more in Biote... | READ MORE

Applications open for Bridge Program

13 April 2017 via Biotech Dispatch: Expressions of interest are now open for the Bridge Program. The Program, a consortium of 14 partners including global life sciences companies, venture capitalists, universities and industry associations, will be launched by QUT i... | READ MORE

Jump to page